Evexia promoter group buys 42.4 lakh shares in open market
- Promoter group entity Shree Saibaba Exim Private Limited bought 42,42,111 equity shares
- Post-transaction stake rises to 6.794% from 6.568%
- Transaction executed via open market on BSE on September 29, 2026

*this image is generated using AI for illustrative purposes only.
Evexia Lifecare Limited reported that its promoter group entity, Shree Saibaba Exim Private Limited, acquired 42,42,111 equity shares on September 29, 2026. This open market purchase increases the promoter group's holding to 6.794% of the company's total share capital.
The disclosure was made under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction was executed on the BSE Limited exchange.
Stake increase details
The acquisition represents a 0.225% increase in the promoter group's shareholding. Prior to this transaction, Shree Saibaba Exim Private Limited held 12,33,07,716 shares, constituting 6.568% of the company. Following the purchase, the holding stands at 12,75,49,827 shares.
| Metric | Before Acquisition | After Acquisition | Change |
|---|---|---|---|
| Number of Shares | 12,33,07,716 | 12,75,49,827 | +42,42,111 |
| Percentage Holding | 6.568% | 6.794% | +0.225% |
The transaction value is listed as 4242111 in the disclosure form, excluding taxes, brokerage, or other charges. The mode of acquisition was specified as Open Market.
Regulatory compliance
The intimation was signed by Artiben Jayeshbhai Thakkar, Director of Shree Saibaba Exim Private Limited. The company's Managing Director, Jayesh R. Thakkar, forwarded the disclosure to BSE Limited for record-keeping. No trading in derivatives was reported by the promoter group during this period.
Historical Stock Returns for Evexia Lifecar
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.06% | +3.24% | +29.93% | +247.27% | -7.73% | -72.12% |
Will the promoter group's continued accumulation of shares push their holding above the 10% threshold, potentially triggering additional SEBI disclosure requirements?
How does this open market purchase correlate with recent operational announcements or financial performance trends at Evexia Lifecare?
Is this acquisition part of a broader strategy to consolidate control ahead of potential corporate actions like buybacks or private placements?


































